Biogen Inc (BIIB)
190.45
-1.71
(-0.89%)
USD |
NASDAQ |
Apr 18, 16:00
190.50
+0.05
(+0.03%)
After-Hours: 20:00
Biogen Total Long Term Debt (Quarterly): 6.938B for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 6.938B |
September 30, 2023 | 7.286B |
June 30, 2023 | 6.285B |
March 31, 2023 | 6.283B |
December 31, 2022 | 6.281B |
September 30, 2022 | 6.279B |
June 30, 2022 | 7.277B |
March 31, 2022 | 7.275B |
December 31, 2021 | 7.273B |
September 30, 2021 | 7.271B |
June 30, 2021 | 7.269B |
March 31, 2021 | 7.267B |
December 31, 2020 | 7.426B |
September 30, 2020 | 7.425B |
June 30, 2020 | 7.424B |
March 31, 2020 | 5.962B |
December 31, 2019 | 5.955B |
September 30, 2019 | 5.954B |
June 30, 2019 | 5.948B |
March 31, 2019 | 5.943B |
December 31, 2018 | 5.936B |
September 30, 2018 | 5.931B |
June 30, 2018 | 5.928B |
March 31, 2018 | 5.933B |
December 31, 2017 | 5.938B |
Date | Value |
---|---|
September 30, 2017 | 6.512B |
June 30, 2017 | 6.514B |
March 31, 2017 | 6.514B |
December 31, 2016 | 6.517B |
September 30, 2016 | 6.534B |
June 30, 2016 | 6.543B |
March 31, 2016 | 6.540B |
December 31, 2015 | 6.526B |
September 30, 2015 | 6.534B |
June 30, 2015 | 579.47M |
March 31, 2015 | 583.93M |
December 31, 2014 | 583.40M |
September 30, 2014 | 587.20M |
June 30, 2014 | 589.48M |
March 31, 2014 | 594.56M |
December 31, 2013 | 595.89M |
September 30, 2013 | 698.28M |
June 30, 2013 | 729.58M |
March 31, 2013 | 915.15M |
December 31, 2012 | 1.141B |
September 30, 2012 | 1.112B |
June 30, 2012 | 1.095B |
March 31, 2012 | 1.079B |
December 31, 2011 | 1.064B |
September 30, 2011 | 1.064B |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
5.948B
Minimum
Jun 2019
7.426B
Maximum
Dec 2020
6.794B
Average
7.267B
Median
Mar 2021
Total Long Term Debt (Quarterly) Benchmarks
Eli Lilly and Co | 25.23B |
Bristol-Myers Squibb Co | 39.77B |
AbbVie Inc | 59.38B |
Amgen Inc | 64.61B |
Regeneron Pharmaceuticals Inc | 1.983B |